Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Timolol/Dorzolamide on Autoregulation in Glaucoma
NCT02053298Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dorzolamide in primary open-angle glaucoma (POAG), normal tension glaucoma (NTG), sponsored by UZ Leuven. Started Jan 2014; status: completed.
02
Drugs
dorzolamide
03
Conditions
primary open-angle glaucoma (POAG)normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT02053298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053298.